A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

Clinical trial NCT05727267 · COMPLETED

Trial details

NCT number: NCT05727267
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2024-01-23
Primary completion: 2026-05-21
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.